IL-6 Inhibitors, which are now considered as promising treatment for COVID-19, target the IL-6 receptors (IL-6Rs), thereby preventing the binding of IL-6 ligands to IL-6 receptors. Thus, inhibiting the entire IL-6 signal transduction . The Interleukin 6 (IL-6) family is a large and diverse group of cytokines (IL-6, IL-11, IL-27, IL-31, OSM, LIF, CNTF, CT-1 and CLCF1) that is defined based on the use of common β-receptor signaling subunits, which could induce fever in patients
This report contains market size and forecasts of IL-6 Inhibitors in Global, including the following market information:
Global IL-6 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IL-6 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IL-6 Receptors Antagonistic Anitibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IL-6 Inhibitors include Roche, Regeneron Pharmaceuticals Inc., Sanofi, Janssen Global Services LLC, Novimmune SA and UCB Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IL-6 Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IL-6 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IL-6 Inhibitors Market Segment Percentages, by Type, 2021 (%)
IL-6 Receptors Antagonistic Anitibody
Antibody against IL-6
Global IL-6 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IL-6 Inhibitors Market Segment Percentages, by Application, 2021 (%)
Autoimmune Diease Treatment
Ajuvant Cancer Treatment
COVID-19 Therapy
Global IL-6 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IL-6 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IL-6 Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IL-6 Inhibitors revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Regeneron Pharmaceuticals Inc.
Sanofi
Janssen Global Services LLC
Novimmune SA
UCB Pharma